Andreas Dietz

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.6K citations · Full text

Medicine, Pathology, Head And Neck Cancer +5

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer

S. Staar, Volker Rudat, Hartmut Stuetzer et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 359 citations

Radiation Medicine, Advanced Head-and-neck Cancer, Radiation Therapy +9

Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control.

Thomas Andl, Tomas Kahn, Andreas Pfuhl et al. · PubMed · 1998 · 283 citations

Pathology, Tumor Biology, Carcinoma +18

Tobacco and alcohol and the risk of head and neck cancer

H. Maier, Andreas Dietz, U. Gewelke et al. · Journal of Molecular Medicine · 1992 · 272 citations

Tobacco Control, Substance Abuse, Neck Cancer +11

Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis

Heide Götze, Michael Friedrich, Sabine Taubenheim et al. · Supportive Care in Cancer · 2019 · 271 citations

Psychological Co-morbidities, Psychiatry, Mood Symptom +8